Trademark: 79266161
Status Date
Thursday, June 11, 2020
Filing Date
Friday, July 19, 2019
Published for Opposition
Tuesday, November 19, 2019
Abandoned Date
Thursday, June 11, 2020
5 Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease
Aug 14, 2022
New Representative At Ib Received
Jul 4, 2021
Final Decision Transaction Processed By Ib
Jun 11, 2021
Final Disposition Notice Sent To Ib
Jun 11, 2021
Final Disposition Notice Created, To Be Sent To Ib
Dec 18, 2020
Change Of Name/Address Rec'd From Ib
Jun 11, 2020
Abandonment Notice Mailed - Inter Partes Decision
Jun 11, 2020
Abandonment - After Inter Partes Decision
Jun 11, 2020
Opposition Terminated No. 999999
Jun 11, 2020
Opposition Dismissed No. 999999
May 15, 2020
Notification Processed By Ib
Apr 10, 2020
Refusal Processed By Ib
Mar 20, 2020
Opposition Instituted No. 999999
Mar 17, 2020
Opposition Notice (Ib Refusal) Sent To Ib
Mar 17, 2020
Opposition Notice (Ib Refusal) Created
Nov 19, 2019
Extension Of Time To Oppose Received
Nov 19, 2019
Published For Opposition
Oct 30, 2019
Notification Of Possible Opposition Sent To Ib
Oct 30, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 30, 2019
Notice Of Publication
Oct 11, 2019
Assigned To Lie
Oct 9, 2019
Approved For Pub - Principal Register
Oct 4, 2019
Assigned To Examiner
Sep 13, 2019
Application Filing Receipt Mailed
Sep 9, 2019
New Application Office Supplied Data Entered In Tram
Aug 29, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
